Treatment patterns and outcomes of patients with metastatic non ...

Real-world treatment patterns suggest that chemotherapy use remains high despite guidelines recommending immunotherapy-based 1L treatment ...

The landscape of non-small cell lung cancer (NSCLC) therapy is rapidly changing. This analysis aimed to understand patient characteristics, ...

Real-world treatment patterns and outcomes of patients ... - PubMed

Real-world treatment patterns and outcomes of patients with metastatic nonsquamous non-small cell lung cancer after progression on standard-of-care therapy in ...

Treatment patterns and outcomes in patients with non-small cell ...

The overall 5-years survival rate was 23.7% (35,9% in non-metastatic, 16,3% in metastatic) (Graphs 3 and 4). The median survival time was 1.98 ...

Real-world treatment patterns and outcomes of patients with ...

Data to guide treatment selection in metastatic nonsquamous (mNSq) non-small cell lung cancer (NSCLC) after progression on current ...

Real-world treatment patterns and outcomes of patients with ...

This real-world study showed that patients with metastatic nonsquamous NSCLC and disease progression following initial SoC line(s) of therapy most often ...

Treatment Patterns and Clinical Outcomes Among Metastatic Non ...

1L treatment was chemotherapy in 9969 (93%) patients, and targeted therapy in 685 (6%). Median OS (mOS) for all patients in 1L was 12.3 months (95% confidence ...

Real-World Treatment Patterns and Clinical Outcomes After ...

To characterize treatment patterns and real-world clinical outcomes of patients with metastatic non–small cell lung cancer (mNSCLC) who ...

Treatment Patterns and Clinical Outcomes Among Patients with ...

For patients with metastatic non-small cell lung cancer, timely molecular testing is essential to determine the appropriate course of ...

Treatment Patterns in Patients with Metastatic Non-Small-Cell Lung ...

Clinical trials of I-O regimens have demonstrated improvements in clinical outcomes over CT alone [Citation5–9] and I-O treatments are now approved as ...

Real-world study of treatment patterns and clinical outcomes in ...

Real-world study of treatment patterns and clinical outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) post-approval of immunotherapy in ...

Treatment Patterns and Clinical Outcomes in Patients With EGFR ...

The continuation of osimertinib with chemotherapy was associated with superior progression-free survival (PFS; median: 10.1 versus 5.9 months, ...

Treatment Patterns and Clinical Outcomes Among Metastatic Non ...

Among patients who received 1L targeted therapy and continued to 2L, most continued with 2L targeted therapy (227; 33%). Among patients who received maintenance ...

Real-world treatment patterns and outcomes of patients with ...

Objectives: Data to guide treatment selection in metastatic nonsquamous (mNSq) non-small cell lung cancer (NSCLC) after progression on current ...

Treatment Patterns and Overall Survival in Metastatic Non-Small ...

Median OS of patients with metastatic NSCLC was <1 year. Keywords:: carcinoma · chemotherapy · electronic health records · immunotherapy · non-small-cell lung.

Real-World Treatment Patterns and Survival Outcomes for Patients ...

The treatment landscape is evolving rapidly as immunotherapies and targeted therapy are introduced in the non-metastatic setting, creating a need to assess ...

PP01.110 The Relationship Between Social Determinants of Health ...

However, little is known about their influence on treatment patterns or outcomes in patients with metastatic non-small cell lung cancer (NSCLC). This study ...

Real-World Treatment Patterns and Clinical Outcomes Among ...

For patients with epidermal growth factor receptor-mutated (EGFRm) locally advanced/metastatic non-small cell lung cancer (mNSCLC) whose ...

P10.07 Real-World US Treatment Patterns and Clinical Outcomes in ...

This study reports real-world treatment patterns and survival outcomes in patients with advanced/metastatic NSCLC post-ICI/PDC.

105P US real-world treatment patterns and outcomes of metastatic ...

105P US real-world treatment patterns and outcomes of metastatic nonsquamous non-small cell lung cancer (mNSQ NSCLC) patients (pts) after progression on ...